@fudimmarat.bsky.social
Reposted
Heart failure (HF) = common + underrecognized in patients with MASLD.
pubmed.ncbi.nlm.nih.gov/40389356/
✴️ Key findings: ~50% of biopsy-proven MASLD patients suspected to have HF, but only ~20% diagnosed.
➡️ Risk stratification and screening needed!
@fudimmarat.bsky.social
pubmed.ncbi.nlm.nih.gov/40389356/
✴️ Key findings: ~50% of biopsy-proven MASLD patients suspected to have HF, but only ~20% diagnosed.
➡️ Risk stratification and screening needed!
@fudimmarat.bsky.social
May 21, 2025 at 3:26 AM
Heart failure (HF) = common + underrecognized in patients with MASLD.
pubmed.ncbi.nlm.nih.gov/40389356/
✴️ Key findings: ~50% of biopsy-proven MASLD patients suspected to have HF, but only ~20% diagnosed.
➡️ Risk stratification and screening needed!
@fudimmarat.bsky.social
pubmed.ncbi.nlm.nih.gov/40389356/
✴️ Key findings: ~50% of biopsy-proven MASLD patients suspected to have HF, but only ~20% diagnosed.
➡️ Risk stratification and screening needed!
@fudimmarat.bsky.social
🚨 Calling all #HeartFailure friends and colleagues
Our 1⃣st Devices in Heart Failure day at #HFSA
🔬Mechanisms,💡Implementation, 🖐️Hands on 📅 Sep 26 Minneapolis
Details: hfsa.org/asm/hfsa-dev...
Special Events:⭐️Trial Tinder and ♥️Heart Tank
Apply➡️ shorturl.at/qtyn2
Our 1⃣st Devices in Heart Failure day at #HFSA
🔬Mechanisms,💡Implementation, 🖐️Hands on 📅 Sep 26 Minneapolis
Details: hfsa.org/asm/hfsa-dev...
Special Events:⭐️Trial Tinder and ♥️Heart Tank
Apply➡️ shorturl.at/qtyn2
May 9, 2025 at 10:43 PM
🚨 Calling all #HeartFailure friends and colleagues
Our 1⃣st Devices in Heart Failure day at #HFSA
🔬Mechanisms,💡Implementation, 🖐️Hands on 📅 Sep 26 Minneapolis
Details: hfsa.org/asm/hfsa-dev...
Special Events:⭐️Trial Tinder and ♥️Heart Tank
Apply➡️ shorturl.at/qtyn2
Our 1⃣st Devices in Heart Failure day at #HFSA
🔬Mechanisms,💡Implementation, 🖐️Hands on 📅 Sep 26 Minneapolis
Details: hfsa.org/asm/hfsa-dev...
Special Events:⭐️Trial Tinder and ♥️Heart Tank
Apply➡️ shorturl.at/qtyn2
Reposted
Last week, I sat down with @fudimmarat.bsky.social and Rishi Trivedi (@smidtheart.bsky.social) at #ACC25 to talk about interventional heart failure training and how the paradigm is shifting for @tctmd.bsky.social's #FellowsForum.
www.tctmd.com/videos/forma...
www.tctmd.com/videos/forma...
Formalizing Interventional Heart Failure Training?
Marat Fudim and Rishi Trivedi discuss the challenges ahead as the field aims to become more attractive to trainees.
www.tctmd.com
April 7, 2025 at 7:10 PM
Last week, I sat down with @fudimmarat.bsky.social and Rishi Trivedi (@smidtheart.bsky.social) at #ACC25 to talk about interventional heart failure training and how the paradigm is shifting for @tctmd.bsky.social's #FellowsForum.
www.tctmd.com/videos/forma...
www.tctmd.com/videos/forma...
Reposted
The emerging subspecialty of interventional HF could help fill the gap in trained physicians available to treat an increasingly complex group of pts, experts argue in a new consensus doc @fudimmarat.bsky.social @richardcheng.bsky.social @scainews.bsky.social #CardioSky
www.tctmd.com/news/it-time...
www.tctmd.com/news/it-time...
Is It Time for an ‘Interventional Heart Failure’ Subspecialty?
Merging interventional and AHFTC training programs would be a boon for patients and the HF subspecialty, experts argue.
www.tctmd.com
February 20, 2025 at 2:51 AM
The emerging subspecialty of interventional HF could help fill the gap in trained physicians available to treat an increasingly complex group of pts, experts argue in a new consensus doc @fudimmarat.bsky.social @richardcheng.bsky.social @scainews.bsky.social #CardioSky
www.tctmd.com/news/it-time...
www.tctmd.com/news/it-time...
Reposted
In chapter 1 (⏲️01:25) Michael talks w/ @fudimmarat.bsky.social on the evolving landscape of device-based therapies for #heartfailure treatment and the need for more #clinicaltrials to integrate devices alongside #GMDT. 🔗Full statement, Top 10 Takeaways and Quick Highlights bit.ly/4fwBBMh
December 21, 2024 at 8:13 PM
In chapter 1 (⏲️01:25) Michael talks w/ @fudimmarat.bsky.social on the evolving landscape of device-based therapies for #heartfailure treatment and the need for more #clinicaltrials to integrate devices alongside #GMDT. 🔗Full statement, Top 10 Takeaways and Quick Highlights bit.ly/4fwBBMh